Download Files:
FR-229934
$450 – $3,900
Products Details
Product Description
– FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction[1].
Web ID
– HY-105686
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C21H23Cl2N3O3S
References
– [1]PANDYA J, et, al. Liquid oral formulations for pde v inhibitors. WO2019130052A1.
CAS Number
– 799841-02-4
Molecular Weight
– 468.40
Compound Purity
– 98.65
SMILES
– O=C(C1=CC=C2N=C(C)N(CC3=CC=C(Cl)C(Cl)=C3)C2=C1)NS(=O)(CCCCC)=O
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Isoform
– PDE5
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
